<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiol Spectr</journal-id><journal-id journal-id-type="iso-abbrev">Microbiol Spectr</journal-id><journal-id journal-id-type="pmc-domain-id">3931</journal-id><journal-id journal-id-type="pmc-domain">microbiolspectr</journal-id><journal-id journal-id-type="publisher-id">spectrum</journal-id><journal-title-group><journal-title>Microbiology Spectrum</journal-title></journal-title-group><issn pub-type="epub">2165-0497</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12502630</article-id><article-id pub-id-type="pmcid-ver">PMC12502630.1</article-id><article-id pub-id-type="pmcaid">12502630</article-id><article-id pub-id-type="pmcaiid">12502630</article-id><article-id pub-id-type="pmid">40899851</article-id><article-id pub-id-type="doi">10.1128/spectrum.00755-25</article-id><article-id pub-id-type="publisher-id">spectrum00755-25</article-id><article-id pub-id-type="publisher-id">spectrum.00755-25</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">virology</compound-subject-part><compound-subject-part content-type="label">Virology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Differential olfactory dysfunction and nasal tissue pathology in Syrian hamsters infected with SARS-CoV-2 variants</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6908-0702</contrib-id><name name-style="western"><surname>Saito</surname><given-names initials="T">Takeshi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0360-3360</contrib-id><name name-style="western"><surname>Saito</surname><given-names initials="MH">Marina Hosotani</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reyna</surname><given-names initials="RA">Rachel A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2066-1979</contrib-id><name name-style="western"><surname>Taniguchi</surname><given-names initials="S">Satoshi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Littlefield</surname><given-names initials="KE">Kirsten E.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cook</surname><given-names initials="R">Rebecca</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Underbrink</surname><given-names initials="P">Preston</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="A">Amy</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Makishima</surname><given-names initials="T">Tomoko</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2213-9551</contrib-id><name name-style="western"><surname>Paessler</surname><given-names initials="S">Slobodan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0088-4793</contrib-id><name name-style="western"><surname>Maruyama</surname><given-names initials="J">Junki</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role><email>jumaruya@utmb.edu</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Department of Pathology, University of Texas Medical Branch</institution></institution-wrap>, <city>Galveston</city>, <state>Texas</state>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Department of Otolaryngology, University of Texas Medical Branch</institution></institution-wrap>, <city>Galveston</city>, <state>Texas</state>, <country>USA</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>Department of Microbiology &amp; Immunology, University of Texas Medical Branch</institution></institution-wrap>, <city>Galveston</city>, <state>Texas</state>, <country>USA</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name name-style="western"><surname>Bello</surname><given-names initials="A">Alexander</given-names></name><aff><institution-wrap><institution>National Microbiology Laboratory</institution></institution-wrap>, <city>Winnipeg</city>, <state>Manitoba</state>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Junki Maruyama, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:jumaruya@utmb.edu">jumaruya@utmb.edu</email></corresp><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>10</month><year>2025</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>9</month><year>2025</year></pub-date><volume>13</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">498474</issue-id><elocation-id>e00755-25</elocation-id><history><date date-type="received"><day>12</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>08</day><month>10</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-10-08 10:25:16.343"><day>08</day><month>10</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Saito et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Saito et al.</copyright-holder><ali:free_to_read start_date="2025-09-03"/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="spectrum.00755-25.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="spectrum.00755-25.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the global coronavirus disease 2019 (COVID-19) pandemic, frequently induces olfactory dysfunction (OD), a symptom that significantly impacts patients' quality of life. Understanding the variability in OD and nasal tissue pathology across different SARS-CoV-2 variants may provide insights as to the mechanisms underlying this symptom and inform therapeutic strategies for COVID-19-related sequelae. This study examines the OD and associated nasal pathology in Syrian hamsters infected with SARS-CoV-2 variants, including Wuhan (WA-1), Alpha, Beta, Gamma, Delta, and Omicron, at 5 days post-infection. Olfactory function was assessed using buried food detection tests. Hamsters infected with the WA-1, Alpha, Beta, and Gamma variants exhibited prolonged discovery times as compared to controls, indicating severe OD. In contrast, those infected with the Delta and Omicron variants showed minimal or mild delays. Pathological examination of the lateral turbinate (LT) revealed severe olfactory epithelial damage in WA-1, Alpha, Beta, Gamma, and Delta variant infections, while the Omicron variant caused minimal damage. Viral antigens were detected in retained and/or sloughed epithelial cells in the LT across all variant infections. These results demonstrate significant differences in OD severity and nasal tissue damage among SARS-CoV-2 variants, providing critical insights for understanding the pathogenesis of this symptom and guiding treatment development for COVID-19 sequelae.</p><sec><title>IMPORTANCE</title><p>Olfactory dysfunction (OD) is a prominent and distinctive symptom of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection that significantly affects patients' quality of life. This study reveals that Syrian hamsters infected with different SARS-CoV-2 variants (WA-1, Alpha, Beta, Gamma, Delta, and Omicron) exhibit varying degrees of OD and nasal tissue pathology. Hamsters infected with the WA-1, Alpha, Beta, and Gamma variants experienced significant OD, while those infected with Delta and Omicron showed milder symptoms. Severe epithelial damage in the nasal turbinate was observed in hamsters infected with WA-1, Alpha, Beta, Gamma, and Delta variants, whereas Omicron variant infection resulted in minimal tissue injury. Despite the variability in OD and tissue damage, viral antigen was detected in all infected hamsters. These findings underscore the diverse impact of SARS-CoV-2 variants on olfactory function and nasal tissue pathology, providing important insights into the pathogenesis of OD and guiding potential therapeutic strategies for coronavirus disease 2019-related olfactory sequelae.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>SARS-CoV-2</kwd><kwd>animal model</kwd><kwd>olfactory dysfunction</kwd><kwd>hamster</kwd><kwd>offactory histopathology</kwd><kwd>behavioral test</kwd></kwd-group><counts><count count="3" count-type="supplementary-material"/><count count-type="authors" count="11"/><fig-count count="4"/><table-count count="1"/><equation-count count="0"/><ref-count count="33"/><page-count count="13"/><word-count count="6619"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Although most SARS-CoV-2 infections result in no symptoms or mild flu-like symptoms, some patients experience severe pneumonia, requiring immediate medical care (<xref rid="B1" ref-type="bibr">1</xref>). A unique symptom in COVID-19 is olfactory dysfunction (OD), or anosmia (<xref rid="B2" ref-type="bibr">2</xref>). COVID-19 is characterized by a high prevalence of anosmia, between 33.9% and 85.6%, which is higher than other viral infectious diseases, occurring with sudden onset and typically short duration (<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">&#8211;</xref><xref rid="B6" ref-type="bibr">6</xref>). Anosmia and taste dysfunction may be the sole symptoms without accompanying nasal congestion or rhinorrhea. These chemosensory deficits usually last from several days to around 2 weeks, with most cases improving within 7&#8211;10 days (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). The long-term effect of SARS-CoV-2 infection on olfactory function remains unknown. The unique timing and duration of the anosmia provide crucial insights into the potential mechanisms underlying SARS-CoV-2-induced anosmia.</p><p>During the first year of the global COVID-19 pandemic, the prototypic strain of SARS-CoV-2 (WA-1) deviated into several variants of concern (VoCs), such as Alpha (B.1.17), Beta (B.1.351), and Gamma (P.1). These VoCs were subsequently almost entirely supplanted by the Delta variant (B1.617.2). By 2021&#8211;2022, the Delta variant was replaced by the Omicron variant (B.1.1.529) along with its sub-lineages (e.g., BA.1, BA.2, and BA.5), as well as various recombinant forms like XBBs (<xref rid="B9" ref-type="bibr">9</xref>). In 2023, the BA.2.86 sub-variant of Omicron was detected. Subsequently, JN.1, which diverged from the BA.2.86 as the parent strain, was detected, and JN.1 and its sub-lineages (e.g., JN.1.7, KP.2, and KP.3) are the major variants prevalent in the United States in 2024 (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>The symptoms caused by SARS-CoV-2 variant infections and their severity can vary based on the genetic mutations within each variant, previous infection history, vaccination status, and overall health condition and immune status in patients (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). There have been reports of varying incidence rates of anosmia among these variants (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>). However, the severity of anosmia linked to different SARS-CoV-2 variants has not yet been extensively studied in animal models, and the underlying mechanisms remain to be fully elucidated.</p><p>Syrian hamsters serve as a suitable animal model for studying SARS-CoV-2 due to their susceptibility to infection with low mortality, significant pathological features reflective of COVID-19 patients, and immunocompetent nature (<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">&#8211;</xref><xref rid="B16" ref-type="bibr">16</xref>). Our prior studies have shown that SARS-CoV-2 WA-1-infected hamsters experience significant damage to their olfactory epithelium in the nasal turbinates within three days after infection, a finding supported by behavioral tests indicating olfactory dysfunction (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), demonstrating that hamsters can also be utilized to study for OD caused by SARS-CoV-2 infection.</p><p>In this study, using the hamster model, we investigated the degree of anosmia and tissue damage in the olfactory epithelium caused by infection with the prototype SARS-CoV-2 strain (WA-1) and variants of the Alpha, Beta, Gamma, Delta, and Omicron. We employed the buried food detection test to evaluate OD and conducted histopathological analysis to assess tissue damage in the olfactory epithelium.</p></sec><sec sec-type="materials|methods" id="s2"><title>MATERIALS AND METHODS</title><sec id="s2-1"><title>Cells and viruses</title><p>African green monkey kidney Vero E6 cells were grown in Dulbecco&#8217;s modified Eagle&#8217;s medium (DMEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Gibco), 100 U/mL penicillin, and 0.1 mg/mL streptomycin (Gibco) at 37&#176;C in a 5% CO<sub>2</sub> incubator. SARS-CoV-2 (USA/WA-1/2020) and Alpha (B.1.1.7; USA/CA-CDC5574/2020), Beta (B.1.351; MD-HP01542/2021), Gamma (P.1; MD-MDH-0841/2021), Delta (B.1.617.2; GNL-751), and Omicron (B.1.1.529; hCoV/EHC_C19_2811C) variants were received from the World Reference Center for Emerging Viruses and Arboviruses at the University of Texas Medical Branch (UTMB) and propagated in Vero E6 cells with DMEM supplemented with 2% FBS. Cell culture supernatants were stored at &#8722;80&#176;C until use. All work with infectious SARS-CoV-2 was approved by the Institutional Biosafety Committee at UTMB and performed in BSL-3 facilities at UTMB in accordance with institutional guidelines.</p></sec><sec id="s2-2"><title>Virus titration</title><p>Lung samples collected from SARS-CoV-2-infected hamsters were homogenized in DMEM supplemented with 2% FBS. Cell culture supernatants of SARS-CoV-2 variants or the lung homogenates were 10-fold serially diluted in DMEM with 2% FBS and inoculated into Vero E6 cells on 96-well plates. Four days after inoculation, the plates were fixed with 10% buffered formalin and stained with 0.25% crystal violet to visualize the cytopathic effect. The 50% tissue culture infectious dose (TCID<sub>50</sub>) value was determined by the Reed and Muench method (<xref rid="B18" ref-type="bibr">18</xref>).</p></sec><sec id="s2-3"><title>Animal experiments</title><p>Five- to six-week-old female Syrian golden hamsters were purchased from Charles River Laboratories according to the previous studies (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). We did not consider sex differences in this study. Seven groups of five hamsters were intranasally inoculated with either 10<sup>5</sup> TCID<sub>50</sub> of SARS-CoV-2 WA-1, Alpha, Beta, Gamma, Delta, or Omicron variants diluted in 100 &#181;L of sterile PBS or sterile PBS as mock infection. The body weight of animals was measured daily after the virus infection throughout the study for 5 days. All animals were subjected to a buried food detection test, as previously described (<xref rid="B16" ref-type="bibr">16</xref>), to investigate olfactory function at 5 days post-infection (dpi). After the behavioral test, the animals were euthanized to collect nasal turbinates and lungs for histopathological analysis or virus titration. All hamsters were housed in the animal biosafety level-2 (ABSL-2) and ABSL-3 facilities in the Galveston National Laboratory at UTMB. All animal studies are reviewed and approved by the Institutional Animal Care and Use Committee at UTMB and performed with the National Institutes of Health guidelines. This study is reported in accordance with ARRIVE guidelines (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://arriveguidelines.org/arrive-guidelines" ext-link-type="uri">https://arriveguidelines.org/arrive-guidelines</ext-link>).</p></sec><sec id="s2-4"><title>Behavioral testing</title><p>The buried food detection test was performed to examine olfactory function, as previously reported (<xref rid="B16" ref-type="bibr">16</xref>). A housing cage with at least 3 cm of bedding was prepared, and a honey-flavored teddy graham (Nabisco) was buried in one corner approximately 1 cm below the surface. A hamster was placed in the corner diagonal from the hidden cookie, the lid was closed, and the time until the hamster found and grasped the cookie was recorded. All hamsters were given a maximum of 300 s to find the buried cookie.</p></sec><sec id="s2-5"><title>Histological analysis</title><p>Collected nasal turbinates were fixed with 10% buffered formalin for 7 days with a formalin change after 24 h before removal from the BSL-3 facilities. The olfactory bulbs and nasal tissue were extracted from the skull and decalcified with 10% EDTA and embedded in paraffin. The paraffin-embedded tissues were then sectioned at 5 &#181;m and stained with hematoxylin and eosin (HE). The scoring of olfactory epithelium damage was performed, as previously described (<xref rid="B16" ref-type="bibr">16</xref>). Briefly, each of the four turbinate zones including nasal septa (S), medial turbinate (MT), dorsal turbinate (DT), and lateral turbinate (LT) was assigned an epithelial damage score: 0&#8212;no damage (normal), 1&#8212;mild damage (damage reaches only through epithelial layer; basal layer remains untouched), 2&#8212;moderate damage (up to 75% of damage reaches basal cells), or 3&#8212;severe damage (over 75% of damage reaches basal cells). Scores were averaged between the four reviewers in a blinded manner. The HE-stained sections were imaged using an Olympus IX 71 microscope (Olympus) with a Nikon Digital Sight 1000 digital camera (Nikon) and Nikon NIS-Elements F software (Nikon).</p></sec><sec id="s2-6"><title>Immunohistochemistry</title><p>The deparaffinized sections were incubated for 20 min in a rice cooker in either 10 mM Tris-1 mM EDTA buffer (pH 9.0) for rabbit anti-Iba1 antibody (FUJIFILM Wako Chemicals, 013-27691) or in Target Retrieval Solution (Dako) for rabbit anti-SARS nucleocapsid protein (N) antibody (NOVUS, NB100-567576). The sections were soaked in 3% hydrogen peroxide solution and then incubated with protein blocking solution (Dako) for 15 min at room temperature. The sections were incubated overnight with anti-Iba1 antibody or anti-SARS N antibody at a dilution of 1:1,000 at 4&#176;C. After washing with PBS, the sections were incubated with SignalStain Boost IHC detection reagent (HRP, Rabbit) (Cell Signaling Technology, 8114S) for 30 min. The immunohistochemical reactions were developed with 3,3&#8242;-diaminobenzidine tetrahydrochloride-hydrogen peroxide solution. The sections were lightly stained with hematoxylin and sealed with a coverslip in a mounting medium. The stained sections were examined and images were captured using an Olympus IX 71 microscope with a Nikon Digital Sight 1000 digital camera and Nikon NIS-Elements F software. The scoring of the distribution of viral antigen in each of four turbinate zones was assigned a score using IHC sections labeled with anti-SARS N antibody: 0&#8212;0% of immunoreactive positive cells, 1&#8212;&lt;20% of immunoreactive positive cells, and 2&#8212;&gt;20% immunoreactive positive cells in the olfactory epithelium composing cells. The scoring of the distribution of Iba1-positive macrophages in each of four turbinate zones was assigned a score using IHC sections labeled with anti-Iba1 antibody: 0&#8212;&lt;10% of positive reaction, 1&#8211;10&lt;30% of positive reaction, and 2&#8212;&gt;30% positive reaction in the olfactory epithelium. Each score was averaged between the four reviewers in a blinded manner.</p></sec><sec id="s2-7"><title>Histoplanimetry of olfactory glands</title><p>The alcian blue stained-sections were used for the detection and histoplanimetry of olfactory glands (Bowman&#8217;s glands). The percentage of blue-stained area in the whole lamina propria in three randomly selected regions was calculated and averaged using Colour Deconvolution 1.7 plugin provided in Fiji (National Institutes of Health, Bethesda, MD, USA).</p></sec><sec id="s2-8"><title>Statistical analysis</title><p>All data were analyzed using GraphPad Prism version 10.2.1 software. For comparison of weight change at each time point, we performed a two-way analysis of variance (ANOVA), followed by Dunnett&#8217;s post hoc test. For comparison of virus titer in the lung, behavioral test, histopathological score, and histoplanimetry of olfactory gland, we performed one-way repeated-measures ANOVA, followed by Dunnett&#8217;s test. Correlations were determined using a Pearson correlation test. <italic toggle="yes">P</italic> &lt; 0.05 was deemed statistically significant for all analyses.</p></sec></sec><sec sec-type="results" id="s3"><title>RESULTS</title><sec id="s3-1"><title>Pathogenicity of SARS-CoV-2 variants and anosmia caused by SARS-CoV-2 variant infection in hamsters</title><p>Syrian hamsters were inoculated intranasally with 10<sup>5</sup> TCID<sub>50</sub> of SARS-CoV-2 (WA-1) or its variants; Alpha, Beta, Gamma, Delta, and Omicron variants, and monitored for signs of illness and body weight change (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). The WA-1, Beta, and Gamma variants-infected hamsters showed significant weight loss from 2 to 5 dpi compared to the negative control of infection (PBS). Animals infected with Alpha or Delta variants developed minor weight loss at 2 dpi and recovered by 3 dpi. The Omicron variant-infected hamsters did not show body weight loss. None of the SARS-CoV-2-infected animals or mock-infected animals showed any visible signs of illness. At 5 dpi, anosmia was investigated through a buried food detection test (<xref rid="F1" ref-type="fig">Fig. 1B</xref>) (<xref rid="B16" ref-type="bibr">16</xref>). The PBS-inoculated animals found the hidden cookies in an average of 24.46 s. Cookie-finding time was significantly extended in WA-1, Alpha, Beta, or Gamma variant-infected hamsters, with average times of 118.55, 148.38, 133.41, and 122.86 s, respectively. One of the Alpha variant-infected animals was unable to find the cookie until the 300 s time limit. In the Omicron-infected animals, there was no significant increase in cookie-finding time compared to PBS inoculation, although one animal required longer than the others, at 85.26 s. After behavioral testing, lung and nasal samples were collected for virus titration and histological analysis. The lung samples of WA-1, Alpha, Beta, Gamma, and Delta variant-infected hamsters had detectable viral titers with mean viral loads measuring 3.57, 4.57, 4.90, 5.65, 3.47 log<sub>10</sub> TCID<sub>50</sub>/g, respectively (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Three of the five lung samples from Omicron variant-infected hamsters did not show viral titers above the detection limit (1.50 log<sub>10</sub> TCID<sub>50</sub>/g), while the average of the two detectable samples was 3.30 log<sub>10</sub> TCID<sub>50</sub>/g.</p><fig position="float" fig-type="figure" id="F1" orientation="portrait"><label>Fig 1</label><caption><p>Pathogenicity of SARS-CoV-2 variants and anosmia caused by SARS-CoV-2 variants infection in hamsters. (<bold>A</bold>) Body weight changes of hamsters after SARS-CoV-2 WA-1, Alpha, Beta, Gamma, Delta, or Omicron variant infection. The symbols represent mean group weight changes and the bars represent standard errors. Significant differences between SARS-CoV-2 variants and PBS-inoculated groups at each time point were determined by a two-way ANOVA, followed by Dunnett&#8217;s post hoc test. Statistically significant <italic toggle="yes">P</italic> values are indicated in the figure. (<bold>B</bold>) The time required for hamsters to find the hidden cookie was shown in box plots. (<bold>C</bold>) Averages and standard errors of virus titers in the lungs of SARS-CoV-2-inoculated hamsters were plotted. The broken line indicates the limit of detection (&lt;1.50 log<sub>10</sub> TCID<sub>50</sub>/g). Significant differences in the time required to find the hidden cookie and virus titers compared to PBS-inoculated group were determined by one-way ANOVA, followed by Dunnett&#8217;s post hoc test. Statistically significant <italic toggle="yes">P</italic> values are indicated in the figure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00755-25.f001.jpg"><alt-text>Line graph compares percentage weight change over 5 days post-infection. Box plots depict time to find cookie and viral titers across WA-1, Alpha, Beta, Gamma, Delta, Omicron and PBS groups.</alt-text></graphic></fig></sec><sec id="s3-2"><title>Histopathological analysis of the olfactory epithelium of SARS-CoV-2 variant-infected hamsters</title><p>Histopathological analysis was performed on nasal samples collected from SARS-CoV-2 variant-infected hamsters to quantify tissue damage (<xref rid="F2 F3" ref-type="fig">Fig. 2 and 3</xref>; <xref rid="SuF1" ref-type="supplementary-material">Fig. S1</xref>). In WA-1-infected hamsters, nasal tissue damage including degeneration of olfactory epithelial cell alignment, olfactory epithelium cell disruption, and shortening of cilia was severe in S, MT, DT, and LT regions. In particular, the tissue damage in the LT region was the most severe with an average histopathology score of 2.56. In Alpha-infected animals, the tissue damage in S, MT, and DT was less severe, but the damage in LT was also significant with an average histopathology score of 2.16. Tissue damage in the LT region tended to be most severe of the four regions, even in the Beta-, Gamma-, and Delta-infected hamsters with average histopathology scores of 1.84, 2.24, and 2.12, respectively. In Omicron-infected hamsters, there was no or very little tissue damage in the S, MT, and LT regions, though minor tissue damage was observed in the DT region with disruption of olfactory epithelium cell alignment.</p><fig position="float" fig-type="figure" id="F2" orientation="portrait"><label>Fig 2</label><caption><p>Histological and immunohistochemical changes in the dorsal turbinate of hamsters following SARS-CoV-2 variants infection. (Left) Histological analysis. (Middle left) Immunohistochemistry for SARS-CoV-2 antigen. Arrows indicate viral antigen-positive cells. (Middle right) Immunohistochemistry for Iba1-positive macrophages. Brown-stained cells represent Iba1 antigen-positive cells. (Right) Alcian blue staining. Arrows indicate alcian blue-stained olfactory glands. Scale bar represents 50 &#181;m.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00755-25.f002.jpg"><alt-text>Histology images depict nasal tissue from WA-1, Alpha, Beta, Gamma, Delta, Omicron and PBS groups stained with H E, anti-SARS-CoV-2, anti-iba1 and Alcian blue, each indicating differential immune and mucin responses.</alt-text></graphic></fig><fig position="float" fig-type="figure" id="F3" orientation="portrait"><label>Fig 3</label><caption><p>Histopathological score of olfactory epithelium in four nasal turbinate regions: S&#8212;nasal septal, MT&#8212;medial turbinate, DT&#8212;dorsal turbinate, and LT&#8212;lateral turbinate. 0&#8212;no damage (normal), 1&#8212;mild damage (damage reaches only through epithelial layer; basal layer remains untouched), 2&#8212;moderate damage (up to 75% of damage reaches basal cells), and 3&#8212;severe damage (over 75% of damage reaches basal cells). Scores were averaged among four independent reviewers. Significant differences in histopathological score compared to the PBS-inoculated group were determined by one-way ANOVA, followed by Dunnett&#8217;s post hoc test. Statistically significant <italic toggle="yes">P</italic> values are indicated in the figure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00755-25.f003.jpg"><alt-text>Four box plots depict OE damage histology scores for DT, S, MT and LT regions across WA-1, Alpha, Beta, Gamma, Delta, Omicron and PBS groups with statistical comparisons between strains.</alt-text></graphic></fig></sec><sec id="s3-3"><title>Immunohistochemical analysis of the olfactory epithelium of SARS-CoV-2 variant-infected hamsters</title><p>The distribution of viral antigen in the olfactory epithelium of SARS-CoV-2 variant-infected hamsters was investigated using immunohistochemistry (<xref rid="F2" ref-type="fig">Fig. 2</xref>; <xref rid="SuF1" ref-type="supplementary-material">Fig. S2</xref>; <xref rid="SuF2" ref-type="supplementary-material">Table S1</xref>). Viral antigen-positive olfactory epithelial cells were found in both retained and detached olfactory epithelium. In WA-1-infected animals, more virus-infected olfactory epithelial cells were observed in the DT and LT regions compared to the S and MT regions. The Alpha-, Beta-, Gamma-, Delta-, and Omicron variant-infected animals also showed viral antigen-positive cells in the DT and LT regions. In all groups, the number of viral antigen-positive cells in the LT region was similar to or higher than in the DT region. Viral infection of the S region was most commonly observed in the Beta variant-infected group, followed by the Gamma variant-infected group. In the other variant-infected groups, the distribution of the viral antigen-positive cells in this region was absent or minor. In the MT region, more viral antigens were detected in the Beta and Gamma variant-infected groups. In contrast, viral antigens were not detectable in the MT region in Delta and Omicron-infected animals. Interestingly, in the Omicron-infected group, there were areas of viral antigen-positive cells distributed from cilia to epithelial cells in the DT and LT regions. Macrophage infiltration into the lamina propria and the olfactory epithelium was observed in the S, MT, DT, and LT regions to a similar degree in WA-1-, Alpha-, Beta-, and Gamma-infected animals (<xref rid="F2" ref-type="fig">Fig. 2</xref>; <xref rid="SuF1" ref-type="supplementary-material">Fig. S3</xref>; <xref rid="SuF3" ref-type="supplementary-material">Table S2</xref>). On the other hand, macrophage infiltration in the DT region was notable compared to the S, MT, and DT regions in Delta and Omicron-infected animals.</p></sec><sec id="s3-4"><title>Histoplanimetric analysis of the olfactory glands in SARS-CoV-2 variant-infected hamsters</title><p>Through secreting mucus, the olfactory glands in the olfactory tissue play a crucial role in maintaining the health of the olfactory epithelium, ensuring proper olfactory function, and protecting against pathogens (<xref rid="B19" ref-type="bibr">19</xref><xref rid="B20" ref-type="bibr">&#8211;</xref><xref rid="B21" ref-type="bibr">21</xref>). We compared the extent of damage to these glands in hamsters infected with different SARS-CoV-2 variants by measuring the percentage of olfactory gland area stained by alcian blue (<xref rid="F2 F4" ref-type="fig">Fig. 2 and 4</xref>; <xref rid="SuF1" ref-type="supplementary-material">Fig. S4</xref>). In the mock-infected group, the mean blue area percentage was 3.7%, 4.5%, 4.9%, and 3.9% in the S, MT, DT, and LT regions, respectively. In all SARS-CoV-2-infected animals, significant olfactory gland shrinkage ranging from 27% to 80% was observed. In WA-1, Alpha, Beta, and Gamma-infected hamsters, the area of olfactory glands was reduced to less than half, especially in the DT and LT regions of the Gamma-infected group, which lost 80% and 77% of their olfactory glands, respectively.</p><fig position="float" fig-type="figure" id="F4" orientation="portrait"><label>Fig 4</label><caption><p>Histoplanimetry of olfactory glands. The alcian blue-stained sections were used for the detection and histoplanimetry of olfactory glands. The percentage of blue-stained area in the whole lamina propria in three randomly selected regions from four nasal turbinate regions: S&#8212;nasal septal, MT&#8212;medial turbinate, DT&#8212;dorsal turbinate, and LT&#8212;lateral turbinate was calculated and averaged. Significant differences in histopathological score compared to the PBS-inoculated group were determined by one-way ANOVA, followed by Dunnett&#8217;s post hoc test. Statistically significant <italic toggle="yes">P</italic> values are indicated in the figure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00755-25.f004.jpg"><alt-text>Four box plots compare blue area percentage in DT, S, MT and LT regions among WA-1, Alpha, Beta, Gamma, Delta, Omicron and PBS groups with statistical significance across strains.</alt-text></graphic></fig></sec></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>Among the symptoms associated with COVID-19, anosmia or OD is a unique symptom. There have been reports of varying incidence rates of anosmia among SARS-CoV-2 variant infections. However, the severity of anosmia linked to different SARS-CoV-2 variants has not yet been extensively studied in animal models, and the mechanisms underlying OD caused by SARS-CoV-2 infections remain to be fully elucidated. We previously reported that almost 100% of Syrian hamsters showed OD after SARS-CoV-2 WA-1 infection, with phenotypic confirmation by a buried food detection test (<xref rid="B16" ref-type="bibr">16</xref>). No other animal model of OD induced by viral infection has shown such a high rate of OD onset. This hamster model of OD induced by SARS-CoV-2 infection is a powerful tool to reveal the mechanisms underlying post-infection OD caused by viruses through the quantitative assessment of olfactory function.</p><p>The buried food detection tests revealed that SARS-CoV-2 WA-1 and Alpha, Beta, Gamma variants caused significant OD in hamsters at 5 dpi, while Delta and Omicron variants caused little to no OD. The hamsters infected with the Alpha variant did not show significant body weight loss, but they did show significant OD, suggesting that there is a minimal relationship between OD and disease severity as indicated by body weight loss. In human cases, the incidence of OD does not necessarily correlate with the incidence of fever or respiratory symptoms, and OD may be the only symptom present (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Viral replication was observed in the lungs of hamsters infected with the SARS-CoV-2 WA-1, Alpha, Beta, Gamma, and Delta variants. Of note, the viral titer of the Delta variant was as high as that of WA-1, although the Delta variant did not cause significant OD. This is consistent with a previous report indicating that SARS-CoV-2 WA-1 and Gamma variants, but not Delta and Omicron variants, cause significant OD at 3 dpi, which were not associated with viral titer in the lower respiratory tract (<xref rid="B24" ref-type="bibr">24</xref>). These results indicated that there is no relationship between anosmia and viral replication within the lower respiratory tract, and that specific mechanisms in the nasal epithelium cause OD in SARS-CoV-2 infection.</p><p>The presence of the D614G mutation in the spike protein has been reported to enhance anosmia in COVID-19 patients (<xref rid="B25" ref-type="bibr">25</xref>). However, in our olfactory behavioral tests, the SARS-CoV-2 WA-1 lacking this mutation caused significant anosmia in hamsters, while the Delta and Omicron variants with this mutation did not. These results revealed that the D614G mutation is not responsible for the degree of OD. In fact, the global prevalence of Omicron variant-induced OD in adults is estimated to be 3.7%, which is 2&#8211;10 times lower than that caused by the Alpha and Delta variants (<xref rid="B26" ref-type="bibr">26</xref>). In addition, the sub-lineages of the Omicron variants, BA.2, BQ.1, and BQ.1.1 have been reported to cause significant anosmia in hamsters (<xref rid="B27" ref-type="bibr">27</xref>). Thus, the degree of OD is not determined by the D614G mutation, and other differences among SARS-CoV-2 variants are predicted to influence it. The detailed viral factor(s) responsible for OD in SARS-CoV-2 infections can be revealed using reverse genetics in future studies.</p><p>The proposed mechanisms of anosmia include damage to olfactory receptor neurons, viral infiltration into the brain, and damage to the supporting cells of the olfactory epithelium related to olfactory function. Tissue damage in the olfactory epithelium is a more likely mechanism for the early onset of OD in COVID-19, since OD is rapidly reversible and viral infection of neurons is not associated with OD (<xref rid="B8" ref-type="bibr">8</xref>). Tissue injury of the olfactory epithelium in virus-infected hamsters was indeed associated with OD, and tissue damage in different nasal turbinate regions may be responsible for SARS-CoV-2-induced OD. In WA-1, Alpha, Beta, and Gamma variant infections, tissue damage was severe in all regions, including S and MT. In Delta variant infection, severe damage was seen in DT, MT, and LT, whereas severe tissue damage was seen only in DT in Omicron variant infection. From these findings, we determined that the OD caused by SARS-CoV-2 infection involves tissue damage in the specific nasal turbinate region, particularly in the S and MT regions. A Pearson&#8217;s correlation between histopathological score in different nasal turbinate regions and time to find the hidden cookie (<xref rid="T1" ref-type="table">Table 1</xref>) showed a significant positive correlation. In particular, the strongest correlation was found in MT, suggesting that tissue injury in the MT region leads to OD. In addition, viral antigens were detected in DT and LT regions, but not in S and MT regions, in Delta or Omicron variant infections, suggesting that SARS-CoV-2 variants have different infectivity in the nasal turbinate regions, which may contribute to the degree of tissue damage. In humans and mice, the expression patterns of NADPH: quinone oxidoreductase (NQO1), olfactory marker protein, olfactory cell adhesion molecule, and neural cell adhesion molecule differ depending on the nasal turbinate regions (<xref rid="B28" ref-type="bibr">28</xref><xref rid="B29" ref-type="bibr">&#8211;</xref><xref rid="B31" ref-type="bibr">31</xref>). Given that NQO1 is highly expressed in the DT region of the nasal turbinate in hamsters (<xref rid="B32" ref-type="bibr">32</xref>), the expression of this molecule may play a role in the establishment of infection by the Delta and Omicron strains without causing olfactory abnormalities (<xref rid="B33" ref-type="bibr">33</xref>). Macrophage infiltration is also severe in the DT region of hamsters infected with the Delta or Omicron variant, suggesting that inflammation in this region may be less related to OD. This indicates that the spatial distribution of macrophage infiltration, rather than its overall magnitude, may determine its relevance to OD. These findings also raise the possibility that inflammation in distinct olfactory compartments plays varying roles in the development of SARS-CoV-2-induced anosmia.</p><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Pearson&#8217;s correlation coefficient (<italic toggle="yes">r</italic>) between histopathology score, histoplanimetry of olfactory glands and time to find the cookie<xref rid="T1_FN1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="2" colspan="1"/><th align="center" valign="top" colspan="4" rowspan="1">Histopathology score</th><th align="center" valign="top" colspan="4" rowspan="1">Histoplanimetry of olfactory glands</th></tr><tr><th align="left" valign="top" colspan="1" rowspan="1">S</th><th align="left" valign="top" colspan="1" rowspan="1">MT</th><th align="left" valign="top" colspan="1" rowspan="1">DT</th><th align="left" valign="top" colspan="1" rowspan="1">LT</th><th align="left" valign="top" colspan="1" rowspan="1">S</th><th align="left" valign="top" colspan="1" rowspan="1">MT</th><th align="left" valign="top" colspan="1" rowspan="1">DT</th><th align="left" valign="top" colspan="1" rowspan="1">LT</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Pearson&#8217;s <italic toggle="yes">r</italic></td><td align="left" valign="top" colspan="1" rowspan="1">0.5263</td><td align="left" valign="top" colspan="1" rowspan="1">0.6318</td><td align="left" valign="top" colspan="1" rowspan="1">0.4049</td><td align="left" valign="top" colspan="1" rowspan="1">0.5697</td><td align="left" valign="top" colspan="1" rowspan="1">&#8722;0.6026</td><td align="left" valign="top" colspan="1" rowspan="1">&#8722;0.4532</td><td align="left" valign="top" colspan="1" rowspan="1">&#8722;0.5048</td><td align="left" valign="top" colspan="1" rowspan="1">&#8722;0.5486</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</td><td align="left" valign="top" colspan="1" rowspan="1">0.0012</td><td align="left" valign="top" colspan="1" rowspan="1">&lt;0.0001</td><td align="left" valign="top" colspan="1" rowspan="1">0.0158</td><td align="left" valign="top" colspan="1" rowspan="1">0.0004</td><td align="left" valign="top" colspan="1" rowspan="1">0.0001</td><td align="left" valign="top" colspan="1" rowspan="1">0.0063</td><td align="left" valign="top" colspan="1" rowspan="1">0.002</td><td align="left" valign="top" colspan="1" rowspan="1">0.0006</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1"><label>
<sup>
<italic toggle="yes">a</italic>
</sup>
</label><p>A Pearson correlation was performed for the time taken to find the hidden cookie, the histopathology score of the four individual nasal turbinate regions: S&#8212;nasal septal, MT&#8212;medial turbinate, DT&#8212;dorsal turbinate, and LT&#8212;lateral turbinate), and the histoplanmetry of olfactory glands of each turbinate region.</p></fn></table-wrap-foot></table-wrap><p>In addition to tissue damage caused by direct virus infection and immune-cell infiltration, olfactory gland shrinkage in each nasal turbinate region caused by SARS-CoV-2 variant infections may also be associated with OD. In hamsters infected with WA-1, Alpha, Beta, and Gamma, which showed significant OD, there was marked olfactory gland shrinkage in all nasal turbinate regions. On the other hand, Delta or Omicron variant-infected animals showed no significant shrinkage in the S region. This observation is consistent with the mild tissue damage in the S region in Delta and Omicron variant infections, suggesting that olfactory gland shrinkage affects the onset of OD in addition to tissue damage in the S region. There were significant negative Pearson&#8217;s correlations between olfactory gland area and time to find the hidden cookies (<xref rid="T1" ref-type="table">Table 1</xref>). The strongest correlation was found in the S region, indicating that olfactory gland atrophy in this region may also be related to OD. Shrinkage of olfactory glands leads to reduced mucus secretion and disruption of the metabolic microenvironment of the olfactory epithelium (<xref rid="B33" ref-type="bibr">33</xref>). These findings suggest that the regional pattern of olfactory gland shrinkage, as well as the overall extent of shrinkage, may determine its impact on SARS-CoV-2-induced OD.</p><p>Our study reveals that the susceptibility, tissue damage, and immune response in different compartments of the nasal turbinate vary depending on SARS-CoV-2 variants. This variability is characterized by the differential distribution of viral antigens and macrophages, variations in olfactory epithelial damage, and olfactory gland shrinkage, which are related to the degree of OD. This research not only contributes to our knowledge of the impact induced by SARS-CoV-2 infection on the olfactory system but also underscores the importance of variant-specific studies in the ongoing battle against COVID-19.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We would like to thank the UTMB Institutional Biorepository, which provided research histology services in support of this study.</p><p>This work was supported by the Institute for Human Infections and Immunity at the University of Texas Medical Branch and the John S. Dunn Foundation. T.S. was supported by the Uehara Memorial Foundation, the McLaughlin Fellowship Fund, and the Overseas Research Fellowships from the Japanese Society for the Promotion of Science.</p><p>T.S. and J.M. designed the experiments. T.S., M.H.S., R.A.R., S.T., K.E.L., and J.M. performed the experiments. T.S., M.H.S., R.C., P.U., A.W. analyzed data. T.S. and J.M. wrote the paper. All authors reviewed and edited the drafts and approved the final version.</p></ack><sec sec-type="supplementary-material" id="s5-1"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1128/spectrum.00755-25" ext-link-type="uri">https://doi.org/10.1128/spectrum.00755-25</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/spectrum.00755-25.SuF1</object-id><label>Supplemental figures</label><caption><title>spectrum.00755-25-s0001.pdf</title><p>Fig. S1 to S4.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="spectrum.00755-25-s0001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="SuF2" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/spectrum.00755-25.SuF2</object-id><label>Table S1</label><caption><title>spectrum.00755-25-s0002.docx</title><p>Immunohistochemical scoring for SARS-CoV-2 antigen.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="spectrum.00755-25-s0002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="SuF3" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/spectrum.00755-25.SuF3</object-id><label>Table S2</label><caption><title>spectrum.00755-25-s0003.docx</title><p>Immunohistochemical scoring for Iba1.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="spectrum.00755-25-s0003.docx" position="float" orientation="portrait"/></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Guan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tong</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>KSM</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>EHY</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>JY</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2020</year>. <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus&#8211;infected pneumonia</article-title>. <source>N Engl J Med</source><volume>382</volume>:<fpage>1199</fpage>&#8211;<lpage>1207</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id><pub-id pub-id-type="pmcid">PMC7121484</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Giacomelli</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pezzati</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Conti</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bernacchia</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Siano</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Oreni</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rusconi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gervasoni</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ridolfo</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Rizzardini</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Antinori</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Galli</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year>. <article-title>Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study</article-title>. <source>Clin Infect Dis</source><volume>71</volume>:<fpage>889</fpage>&#8211;<lpage>890</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciaa330</pub-id><pub-id pub-id-type="pmid">32215618</pub-id><pub-id pub-id-type="pmcid">PMC7184514</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>Z</given-names></string-name></person-group>. <year>2020</year>. <article-title>COVID-19 and anosmia: a review based on up-to-date knowledge</article-title>. <source>Am J Otolaryngol</source><volume>41</volume>:<fpage>102581</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjoto.2020.102581</pub-id><pub-id pub-id-type="pmid">32563019</pub-id><pub-id pub-id-type="pmcid">PMC7265845</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lechien</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Chiesa-Estomba</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>De Siati</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Horoi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Le Bon</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Dequanter</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Blecic</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>El Afia</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Distinguin</surname><given-names>L</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2020</year>. <article-title>Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study</article-title>. <source>Eur Arch Otorhinolaryngol</source><volume>277</volume>:<fpage>2251</fpage>&#8211;<lpage>2261</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00405-020-05965-1</pub-id><pub-id pub-id-type="pmid">32253535</pub-id><pub-id pub-id-type="pmcid">PMC7134551</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mutiawati</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Fahriani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mamada</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Fajar</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Frediansyah</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Maliga</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Ilmawan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Emran</surname><given-names>TB</given-names></string-name>, <string-name name-style="western"><surname>Ophinni</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ichsan</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Musadir</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rabaan</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Dhama</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Syahrul</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nainu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Harapan</surname><given-names>H</given-names></string-name></person-group>. <year>2021</year>. <article-title>Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis</article-title>. <source>F1000Res</source><volume>10</volume>:<fpage>40</fpage>. doi:<pub-id pub-id-type="doi">10.12688/f1000research.28393.1</pub-id><pub-id pub-id-type="pmid">33824716</pub-id><pub-id pub-id-type="pmcid">PMC7993408</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>von Bartheld</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Hagen</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Butowt</surname><given-names>R</given-names></string-name></person-group>. <year>2020</year>. <article-title>Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences</article-title>. <source>ACS Chem Neurosci</source><volume>11</volume>:<fpage>2944</fpage>&#8211;<lpage>2961</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.0c00460</pub-id><pub-id pub-id-type="pmid">32870641</pub-id><pub-id pub-id-type="pmcid">PMC7571048</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vaira</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Deiana</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fois</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Pirina</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Madeddu</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>De Vito</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Babudieri</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Petrocelli</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Serra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bussu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ligas</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Salzano</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>De Riu</surname><given-names>G</given-names></string-name></person-group>. <year>2020</year>. <article-title>Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases</article-title>. <source>Head Neck</source><volume>42</volume>:<fpage>1252</fpage>&#8211;<lpage>1258</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hed.26204</pub-id><pub-id pub-id-type="pmid">32342566</pub-id><pub-id pub-id-type="pmcid">PMC7267244</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Butowt</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>von Bartheld</surname><given-names>CS</given-names></string-name></person-group>. <year>2021</year>. <article-title>Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection</article-title>. <source>Neuroscientist</source><volume>27</volume>:<fpage>582</fpage>&#8211;<lpage>603</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1073858420956905</pub-id><pub-id pub-id-type="pmid">32914699</pub-id><pub-id pub-id-type="pmcid">PMC7488171</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>WHO COVID-19 Dashboard</collab></person-group>. <year>2024</year>. <article-title>COVID-19 cases</article-title>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://data.who.int/dashboards/covid19/cases" ext-link-type="uri">https://data.who.int/dashboards/covid19/cases</ext-link>. <comment>Retrieved</comment><date-in-citation>29 May 2024</date-in-citation>.</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="webpage"><article-title>CDC COVID data tracker</article-title>. <year>2024</year>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://covid.cdc.gov/covid-data-tracker" ext-link-type="uri">https://covid.cdc.gov/covid-data-tracker</ext-link>. <comment>Retrieved</comment><date-in-citation>30 May 2024</date-in-citation>.</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chatterjee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bhattacharya</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nag</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dhama</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Chakraborty</surname><given-names>C</given-names></string-name></person-group>. <year>2023</year>. <article-title>A detailed overview of SARS-CoV-2 Omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies</article-title>. <source>Viruses</source><volume>15</volume>:<fpage>167</fpage>. doi:<pub-id pub-id-type="doi">10.3390/v15010167</pub-id><pub-id pub-id-type="pmid">36680207</pub-id><pub-id pub-id-type="pmcid">PMC9866114</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Townsley</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Gahir</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Russell</surname><given-names>TW</given-names></string-name>, <string-name name-style="western"><surname>Greenwood</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Carr</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Dyke</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Adams</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Miah</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Clayton</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>C</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2024</year>. <article-title>COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history</article-title>. <source>PLoS One</source><volume>19</volume>:<elocation-id>e0294897</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0294897</pub-id><pub-id pub-id-type="pmid">38512960</pub-id><pub-id pub-id-type="pmcid">PMC10956747</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Menni</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Valdes</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Freidin</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Sudre</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Drew</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Ganesh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Varsavsky</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Cardoso</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>El-Sayed Moustafa</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Visconti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hysi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Bowyer</surname><given-names>RCE</given-names></string-name>, <string-name name-style="western"><surname>Mangino</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Falchi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wolf</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ourselin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Steves</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Spector</surname><given-names>TD</given-names></string-name></person-group>. <year>2020</year>. <article-title>Real-time tracking of self-reported symptoms to predict potential COVID-19</article-title>. <source>Nat Med</source><volume>26</volume>:<fpage>1037</fpage>&#8211;<lpage>1040</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41591-020-0916-2</pub-id><pub-id pub-id-type="pmid">32393804</pub-id><pub-id pub-id-type="pmcid">PMC7751267</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sia</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>L-M</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>AWH</given-names></string-name>, <string-name name-style="western"><surname>Fung</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Choy</surname><given-names>K-T</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>AYL</given-names></string-name>, <string-name name-style="western"><surname>Kaewpreedee</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Perera</surname><given-names>RAPM</given-names></string-name>, <string-name name-style="western"><surname>Poon</surname><given-names>LLM</given-names></string-name>, <string-name name-style="western"><surname>Nicholls</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Peiris</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yen</surname><given-names>H-L</given-names></string-name></person-group>. <year>2020</year>. <article-title>Pathogenesis and transmission of SARS-CoV-2 in golden hamsters</article-title>. <source>Nature</source><volume>583</volume>:<fpage>834</fpage>&#8211;<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2342-5</pub-id><pub-id pub-id-type="pmid">32408338</pub-id><pub-id pub-id-type="pmcid">PMC7394720</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Imai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Iwatsuki-Horimoto</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hatta</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Loeber</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Halfmann</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Nakajima</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ujie</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ito</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2020</year>. <article-title>Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development</article-title>. <source>Proc Natl Acad Sci USA</source><volume>117</volume>:<fpage>16587</fpage>&#8211;<lpage>16595</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.2009799117</pub-id><pub-id pub-id-type="pmid">32571934</pub-id><pub-id pub-id-type="pmcid">PMC7368255</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reyna</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Kishimoto-Urata</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Urata</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Makishima</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Paessler</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Maruyama</surname><given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium</article-title>. <source>Sci Rep</source><volume>12</volume>:<elocation-id>628</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41598-021-04622-9</pub-id><pub-id pub-id-type="pmid">35022504</pub-id><pub-id pub-id-type="pmcid">PMC8755745</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Urata</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Maruyama</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kishimoto-Urata</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sattler</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Cook</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Yamasoba</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Makishima</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Paessler</surname><given-names>S</given-names></string-name></person-group>. <year>2021</year>. <article-title>Regeneration profiles of olfactory epithelium after SARS-CoV-2 infection in golden syrian hamsters</article-title>. <source>ACS Chem Neurosci</source><volume>12</volume>:<fpage>589</fpage>&#8211;<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.0c00649</pub-id><pub-id pub-id-type="pmid">33522795</pub-id><pub-id pub-id-type="pmcid">PMC7874468</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reed</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Muench</surname><given-names>H</given-names></string-name></person-group>. <year>1938</year>. <article-title>A simple method of estimating fifty per cent endpoints</article-title>. <source>Am J Epidemiol</source><volume>27</volume>:<fpage>493</fpage>&#8211;<lpage>497</lpage>. doi:<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wade</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Diouara</surname><given-names>AAM</given-names></string-name>, <string-name name-style="western"><surname>Ngom</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Thiam</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Dia</surname><given-names>N</given-names></string-name></person-group>. <year>2024</year>. <article-title>SARS-CoV-2 and other respiratory viruses in human olfactory pathophysiology</article-title>. <source>Microorganisms</source><volume>12</volume>:<elocation-id>540</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms12030540</pub-id><pub-id pub-id-type="pmid">38543591</pub-id><pub-id pub-id-type="pmcid">PMC10974907</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Butowt</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bilinska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>von Bartheld</surname><given-names>CS</given-names></string-name></person-group>. <year>2023</year>. <article-title>Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms</article-title>. <source>Trends Neurosci</source><volume>46</volume>:<fpage>75</fpage>&#8211;<lpage>90</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tins.2022.11.003</pub-id><pub-id pub-id-type="pmid">36470705</pub-id><pub-id pub-id-type="pmcid">PMC9666374</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Solbu</surname><given-names>TT</given-names></string-name>, <string-name name-style="western"><surname>Holen</surname><given-names>T</given-names></string-name></person-group>. <year>2012</year>. <article-title>Aquaporin pathways and mucin secretion of Bowman&#8217;s glands might protect the olfactory mucosa</article-title>. <source>Chem Senses</source><volume>37</volume>:<fpage>35</fpage>&#8211;<lpage>46</lpage>. doi:<pub-id pub-id-type="doi">10.1093/chemse/bjr063</pub-id><pub-id pub-id-type="pmid">21745799</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sehanobish</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Barbi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fong</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Kravitz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sanchez Tejera</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Asad</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matsumura</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ferastraoaru</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Neill</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Karagic</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Akbar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bottalico</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Peshansky</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rangareddy</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hudes</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Eisenberg</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Nath</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Ow</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Jerschow</surname><given-names>E</given-names></string-name></person-group>. <year>2021</year>. <article-title>COVID-19-induced anosmia and ageusia are associated with younger age and lower blood eosinophil counts</article-title>. <source>Am J Rhinol Allergy</source><volume>35</volume>:<fpage>830</fpage>&#8211;<lpage>839</lpage>. doi:<pub-id pub-id-type="doi">10.1177/19458924211004800</pub-id><pub-id pub-id-type="pmid">33813917</pub-id><pub-id pub-id-type="pmcid">PMC8822197</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Speth</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Singer-Cornelius</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Oberle</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gengler</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Brockmeier</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Sedaghat</surname><given-names>AR</given-names></string-name></person-group>. <year>2020</year>. <article-title>Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics</article-title>. <source>Otolaryngol Head Neck Surg</source><volume>163</volume>:<fpage>114</fpage>&#8211;<lpage>120</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0194599820929185</pub-id><pub-id pub-id-type="pmid">32423357</pub-id><pub-id pub-id-type="pmcid">PMC7240313</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>de Melo</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Perraud</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Alvarez</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Vieites-Prado</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kergoat</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Coleon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tr&#252;eb</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Tichit</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Piazza</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thierry</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hardy</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wolff</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Munier</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Koszul</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Simon-Lori&#232;re</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Thiel</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Lecuit</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lledo</surname><given-names>P-M</given-names></string-name>, <string-name name-style="western"><surname>Renier</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Larrous</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bourhy</surname><given-names>H</given-names></string-name></person-group>. <year>2023</year>. <article-title>Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants</article-title>. <source>Nat Commun</source><volume>14</volume>:<elocation-id>4485</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41467-023-40228-7</pub-id><pub-id pub-id-type="pmid">37495586</pub-id><pub-id pub-id-type="pmcid">PMC10372078</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>von Bartheld</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Hagen</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Butowt</surname><given-names>R</given-names></string-name></person-group>. <year>2021</year>. <article-title>The D614G virus mutation enhances anosmia in COVID-19 patients: evidence from a systematic review and meta-analysis of studies from South Asia</article-title>. <source>ACS Chem Neurosci</source><volume>12</volume>:<fpage>3535</fpage>&#8211;<lpage>3549</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acschemneuro.1c00542</pub-id><pub-id pub-id-type="pmid">34533304</pub-id><pub-id pub-id-type="pmcid">PMC8482322</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>von Bartheld</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name></person-group>. <year>2023</year>. <article-title>Prevalence of olfactory dysfunction with the Omicron variant of SARS-CoV-2: a systematic review and meta-analysis</article-title>. <source>Cells</source><volume>12</volume>:<fpage>430</fpage>. doi:<pub-id pub-id-type="doi">10.3390/cells12030430</pub-id><pub-id pub-id-type="pmid">36766771</pub-id><pub-id pub-id-type="pmcid">PMC9913864</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reyna</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mitchell</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Shinde</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Plante</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Weaver</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Plante</surname><given-names>KS</given-names></string-name></person-group>. <year>2023</year>. <article-title>Vaccination against SARS-CoV-2 does not protect against the development of anosmia in a hamster model</article-title>. <source>Vaccines (Basel)</source><volume>11</volume>:<elocation-id>1564</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/vaccines11101564</pub-id><pub-id pub-id-type="pmid">37896967</pub-id><pub-id pub-id-type="pmcid">PMC10611162</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yoshihara</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kawasaki</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tamada</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fujita</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hayashi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kagamiyama</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mori</surname><given-names>K</given-names></string-name></person-group>. <year>1997</year>. <article-title>OCAM: a new member of the neural cell adhesion molecule family related to zone-to-zone projection of olfactory and vomeronasal axons</article-title>. <source>J Neurosci</source><volume>17</volume>:<fpage>5830</fpage>&#8211;<lpage>5842</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-15-05830.1997</pub-id><pub-id pub-id-type="pmid">9221781</pub-id><pub-id pub-id-type="pmcid">PMC6573213</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Coleman</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Louie</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lane</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Schwob</surname><given-names>JE</given-names></string-name></person-group>. <year>2019</year>. <article-title>Spatial determination of neuronal diversification in the olfactory epithelium</article-title>. <source>J Neurosci</source><volume>39</volume>:<fpage>814</fpage>&#8211;<lpage>832</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3594-17.2018</pub-id><pub-id pub-id-type="pmid">30530861</pub-id><pub-id pub-id-type="pmcid">PMC6382982</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Omura</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mombaerts</surname><given-names>P</given-names></string-name></person-group>. <year>2014</year>. <article-title>Trpc2-expressing sensory neurons in the main olfactory epithelium of the mouse</article-title>. <source>Cell Rep</source><volume>8</volume>:<fpage>583</fpage>&#8211;<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2014.06.010</pub-id><pub-id pub-id-type="pmid">25001287</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Omura</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mombaerts</surname><given-names>P</given-names></string-name></person-group>. <year>2015</year>. <article-title>Trpc2-expressing sensory neurons in the mouse main olfactory epithelium of type B express the soluble guanylate cyclase Gucy1b2</article-title>. <source>Mol Cell Neurosci</source><volume>65</volume>:<fpage>114</fpage>&#8211;<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mcn.2015.02.012</pub-id><pub-id pub-id-type="pmid">25701815</pub-id><pub-id pub-id-type="pmcid">PMC4396857</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ueha</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ito</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Furukawa</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kitabatake</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ouji-Sageshima</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ueha</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Koyama</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Uranaka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kondo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yamasoba</surname><given-names>T</given-names></string-name></person-group>. <year>2022</year>. <article-title>Oral SARS-CoV-2 inoculation causes nasal viral infection leading to olfactory bulb infection: an experimental study</article-title>. <source>Front Cell Infect Microbiol</source><volume>12</volume>:<elocation-id>924725</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2022.924725</pub-id><pub-id pub-id-type="pmid">35770069</pub-id><pub-id pub-id-type="pmcid">PMC9234459</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Doty</surname><given-names>RL</given-names></string-name></person-group>. <year>2022</year>. <article-title>Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health</article-title>. <source>Trends Mol Med</source><volume>28</volume>:<fpage>781</fpage>&#8211;<lpage>794</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmed.2022.06.005</pub-id><pub-id pub-id-type="pmid">35810128</pub-id><pub-id pub-id-type="pmcid">PMC9212891</pub-id></mixed-citation></ref></ref-list></back></article>